Old thread I've found here but related - I'm keen to get insight from anyone familiar with MYX's new US manufacturing facility in Greenville NC and the contract services side of Mayne. Their facility clearly has the technical capabilities to manufacture a significant volume including Schedule II-IV controlled substances, 1 billion+ dose capacity, full capsule making equipment etc.
My interest stems from MYX's existing partnership with ambitious US pharma Corium on a number of projects as mentioned here: Corium Inc. – Partnering
Corium is fully privately owned by Ernesto Bertarelli's family company (the Swiss billionaire who built Serono into the world's 3rd largest biopharma co before selling it to Merck) and they are a pretty serious outfit now. They are about to commence marketing and distribution of a brand new LAT prodrug capsule to treat ADHD called Azstarys which could be very big if it meets its sales targets in the US (FDA approved last month, just pending DEA scheduling now, developed by NASDAQ-listed US biopharma partner KemPharm - comprised of the scientists who previously developed ADHD blockbuster Vyvanse). Corium has basically hired all of the ex Vyvanse launch and sales team, and expects to have it straight into the US market next quarter.
Despite lots of looking, I still cannot work out who is going to be manufacturing this ADHD drug for Corium/KemPharm? Naturally, given the seemingly strong contract manufacturing relationship that already exists between Mayne and Corium, a few of us have been wondering if its Mayne's Metric Contract Services division that might be doing the job ex the Greenville facility? The factory is already FDA compliant and would've been inspected as part of the Azstarys approval process if indeed Mayne is doing it.
If anyone has heard anything in their travels around MYX, or seen any hints in company literature that lends some basis to this theory, I would be grateful to hear of it, cheers!
- Forums
- ASX - By Stock
- MYX
- Pressure to Manufacture Drugs on US Home Soil
MYX
mayne pharma group limited
Add to My Watchlist
3.88%
!
$4.95

Pressure to Manufacture Drugs on US Home Soil, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.95 |
Change
-0.200(3.88%) |
Mkt cap ! $402.1M |
Open | High | Low | Value | Volume |
$5.05 | $5.09 | $4.93 | $824.9K | 165.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16429 | $4.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.08 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16429 | 4.950 |
1 | 3583 | 4.940 |
1 | 2745 | 4.920 |
2 | 1849 | 4.910 |
4 | 2500 | 4.900 |
Price($) | Vol. | No. |
---|---|---|
5.080 | 5000 | 1 |
5.100 | 10000 | 1 |
5.120 | 3630 | 2 |
5.180 | 2200 | 1 |
5.210 | 1000 | 1 |
Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |